Home LiteratureArticle Details
PMID: 6242771 Published · ppublish English Journal Article

Microalbuminuria predicts mortality in non-insulin-dependent diabetics.

Diabetic medicine : a journal of the British Diabetic Association ·Vol. 1 ·No. 1 ·1984-05-00 ·Pages 17-9

Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ

Abstract

Forty-four non-insulin-dependent diabetics (NIDD), all with urine negative to Albustix, were studied in 1966/67. By the end of 1980, 17 had died, all but two from cardiovascular causes. All causes of mortality and time to death were significantly related in univariate analyses to age and to the overnight urinary albumin excretion rate (AER), but not to systolic and diastolic blood pressure levels or to duration of diabetes when the latter was corrected for age. Age and duration were highly correlated with each other. In multivariate analyses age and AER were independent predictors of both mortality and time to death, with AER having the greater degree of significance. Thus subclinically elevated albumin excretion rates ('microalbuminuria') indicate a substantially increased mortality risk in non-insulin-dependent diabetes.

MeSH Terms
Adult Albuminuria Blood Pressure Diabetes Mellitus, Type 2/mortality,physiopathology Female Follow-Up Studies Humans Male Middle Aged Prognosis Serum Albumin
Chemicals
Serum Albumin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Jarrett R J
Viberti G C
Argyropoulos A
Hill R D
Mahmud U
Murrells T J
Article Info
Journal
Diabetic medicine : a journal of the British Diabetic Association
Abbr.
Diabet Med
ISSN
0742-3071
Published
1984-05-00
Pages
17-9
Language
English
Region
England
NLM ID
8500858
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com